HCA Midwest Division (Kansas City) — Kansas City, Missouri

HCA Midwest Division (Kansas City) is a clinical research site located in Kansas City, Missouri, United States 64132.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

HCA Midwest Division (Kansas City) has participated in 1 clinical trials.

Therapeutic areas: Carcinoma, Pancreatic Ductal.

Sponsors: Sumitomo Pharma America, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for HCA Midwest Division (Kansas City)?

HCA Midwest Division (Kansas City) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has HCA Midwest Division (Kansas City) conducted?

HCA Midwest Division (Kansas City) has 1 clinical trials on record. Their work covers Carcinoma, Pancreatic Ductal.

Is HCA Midwest Division (Kansas City) accredited by Crixeo Health?

HCA Midwest Division (Kansas City) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about HCA Midwest Division (Kansas City)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.